Evaluation of Outcomes of Surgical Treatment for Nonspecific Infectious Spondylodiscitis Via Posterior Approach in One Center.
The Use of Posterior Approach for Surgical Treatment of Nonspecific Spondylodiscitis.
1 other identifier
interventional
47
1 country
1
Brief Summary
Non-specific spondylodiscitis is a bacterial infection of the spine that in some cases requires surgical treatment. The basis of surgical treatment is the removal of affected tissues. In this case, the supportive function of the affected area is lost, which also requires stable fixation. Access to the affected part of the spine can be achieved through both anterior and posterior approaches. There is no reliable data yet confirming the advantages of each approach. Our study demonstrated successful surgical treatment of infection foci using posterior approach, no neurological or other complications were occurred. Older patients shown differences in hemoglobin levels, postoperative pain scores, the number of affected vertebrae, types of bacteria and recurrent rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 26, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedJanuary 22, 2026
January 1, 2026
4 years
November 26, 2025
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Surgery time
Surgery time in minutes
From enrollment to the end of surgery at 1 year
Hospital stays
Hospital stays in day
From enrollment to the end of surgery at 1 year
Re-operation
Re-operation number
From enrollment to the 1-year post-surgical treatment follow-up period
Health Questionnaire EuroQol 5 Dimension five levels (EQ-5D-5L)
The EQ-5D-5L descriptive system uses five dimensions and five levels of severity in each dimension. TThe five dimensions include mobility, self-care, activities of daily living, pain and discomfort, and anxiety and depression. The five levels in each dimension are worded as (1) 'not /no problems', (2) 'slight problems', (3) 'moderate problems', (4) 'severe problems' and (5) 'unable to' (mobility, self-care, usual activities), 'extreme' (pain/depression), or 'extremely' (anxiety/depression). Their responses are coded as a number (1, 2, 3, 4 or 5) that corresponds to the respective level of severity: 1 indicates no problems, 2-4 some problems and 3 extreme problems. In this way, a person's health state profile can be defined by a 5-digit number, ranging from 11111 (having no problems in any of the dimensions) to 55555 (having extreme problems in all the dimensions). The assigning of a value to an EQ-5D state is based on the time trade-off (TTO) approach.
From enrollment to the end of surgery at 1 year
VAS-pain after surgery
VAS-pain on the 2nd day after surgery. Visual analog scale (0-10 VAS) and it was categorized using the following terms : no pain (0), mild (1-3), moderate (4-6), severe (7-9), or worse pain.
On the 2nd day after surgery
VAS-pain after discharge
VAS-pain on the 2nd day after discharge. Visual analog scale (0-10 VAS) and it was categorized using the following terms : no pain (0), mild (1-3), moderate (4-6), severe (7-9), or worse pain.
On the 2nd day after discharge
Blood loss during surgery
Blood loss during surgery in ml
During the intervention
Procalcitonin
Procalcitonin level in the blood in ng/mL
On the 2nd day after surgery
C-reactive protein
C-reactive protein in the blood in mg/L (Less than less than 3 mg/L consider be normal)
On the 2nd day after surgery
ESR
Erythrocyte sedimentation rate in mm/hr. Normal ESR ; \<20mm/hr.
On the 2nd day after surgery
White blood cells
White blood cells. The normal number of WBCs in the blood is 4.5 to 11.0 Ă— 109/L.
On the 2nd day after surgery
Hemoglobin
Hemoglobin level in grams per deciliter. Normal hemoglobin for men ranges from 13.5 to 17.5 g/dL. Normal range for women is 12.0 to 15.5 g/dL.
On the 2nd day after surgery
Study Arms (1)
Posterial approach
EXPERIMENTALAll patients with spondilodiscitis admitted to surgical treatment in one center. During the operation, a posterior approach was used to access the source of infection. The incision of the skin, subcutaneous fat, and aponeurosis was made with the patient in the prone position, projecting through the spinous processes of the vertebrae above the infection site and one adjacent vertebra.
Interventions
For the posterior approach, an incision through the skin, subcutaneous fat, and aponeurosis was made with the patient in the prone position, projecting through the spinous processes of the vertebrae above the infection site and one adjacent vertebra. In all cases, a thorough exploration and debridement of the infection site was performed. Bone biopsies were taken from suspected infection sites in all patients for culture.
Eligibility Criteria
You may qualify if:
- \- a deep infection affecting intervertebral discs and adjacent vertebral bodies in thoracolumbar spine region which were classified as B.3.1-2 and C2-C4 according to the Pola classification
You may not qualify if:
- cervical spine region infection
- unwilling to participate in the study,
- patients with SD of a specific etiology
- patients who received only conservative treatment,
- patients with intradural infections.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal Center of Traumatology, Orthopedics and Arthroplasty
Cheboksary, Chuvashskaya Respublika, 428020, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Patients were informed about the upcoming surgery and its outcome - healing from infection. However, due to a lack of specialized medical training, they were unable to evaluate the use of the posterior approach. Outcome assessments were conducted without mentioning the use of the operative approach.
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2025
First Posted
January 20, 2026
Study Start
January 1, 2019
Primary Completion
January 1, 2023
Study Completion
January 1, 2023
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share